Search clinical trials for: paclitaxel liposome
Total 5889 results
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingEsophageal Squamous Cell Carcinoma
-
National Cancer Institute (NCI)RecruitingMalignant Solid NeoplasmUnited States
-
Nanjing Luye Sike Pharmaceutical Co., Ltd.Unknown
-
Qilu Hospital of Shandong UniversityRecruitingAdvanced Gastric or Gastroesophageal Junction AdenocarcinomaChina
-
Peking UniversityUnknown
-
Sun Yat-sen UniversityUnknownNasopharyngeal Carcinoma | ChildrenChina
-
INSYS Therapeutics IncCompletedNeoplasmUnited States, Germany, Netherlands
-
Hunan Cancer HospitalRecruiting
-
Fudan UniversityNot yet recruitingAdvanced Pancreatic CancerChina
-
Nanjing Luye Sike Pharmaceutical Co., Ltd.Unknown
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Spectrum Pharmaceuticals, IncTerminatedVincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaRecurrent Adult Acute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Stage IV Breast Cancer AJCC...United States
-
INSYS Therapeutics IncCompletedNeoplasmUnited States
-
National Cancer Institute (NCI)CompletedAIDS-related Kaposi SarcomaUnited States
-
Shandong Luye Pharmaceutical Co., Ltd.Nanjing Sike Pharmaceutical Co., Ltd.Completed
-
National Cancer Institute (NCI)CompletedDS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
INSYS Therapeutics IncCompleted
-
Nanjing Luye Sike Pharmaceutical Co., Ltd.Unknown
-
Ark Biosciences Inc.CompletedHealthy SubjectsUnited States
-
Nanjing Sike Pharmaceutical Co., Ltd.Unknown
-
Bio-Path Holdings, Inc.RecruitingFallopian Tube Neoplasms | Carcinoma, Ovarian Epithelial | Solid Tumor | Endometrial Cancer | Peritoneal Cancer | Solid Tumor, AdultUnited States
-
Health Science Center of Xi'an Jiaotong UniversityUnknown
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedEsophageal CancerUnited States
-
Nanfang Hospital of Southern Medical UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.RecruitingChemotherapy | ImmunotherapyChina
-
Aurobindo Pharma LtdAxis Clinicals LimitedCompletedVisceral LeishmaniasisBangladesh, India
-
Wei RenRecruitingEsophageal Squamous Cell CarcinomaChina
-
Sun Yat-sen UniversityCompletedEsophageal CarcinomaChina
-
Peking Union Medical CollegeCSPC Ouyi Pharmaceutical Co., Ltd.Unknown
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingRefractory Acute Myeloid Leukemia | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | Persistent DiseaseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Chronic Myelomonocytic Leukemia | Refractory Chronic Myelomonocytic Leukemia | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | Recurrent High Risk Myelodysplastic Syndrome | Refractory High Risk Myelodysplastic Syndrome | Blasts 10-19 Percent of Bone Marrow Nucleated Cells and other conditionsUnited States
-
Second Affiliated Hospital, School of Medicine,...Sun Yat-sen University; Peking University International Hospital; Zhejiang UniversityNot yet recruitingHER2-positive Breast Cancer | Brain MetastasesChina
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States
-
Arcus Biosciences, Inc.Infinity Pharmaceuticals, Inc.CompletedOvarian Cancer | TNBC - Triple-Negative Breast CancerUnited States, Australia
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.Active, not recruiting
-
Borstkanker Onderzoek GroepRoche Pharma AG; Teva PharmaCompletedMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastNetherlands
-
Roswell Park Cancer InstituteJazz PharmaceuticalsRecruitingAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid Leukemia | Therapy-Related Acute Myeloid Leukemia | Acute Myeloid Leukemia With Myelodysplasia-Related ChangesUnited States
-
FoveaGilead SciencesUnknownSepsis | CandidaFrance
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Ovarian Undifferentiated CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Secondary Acute Myeloid LeukemiaUnited States
-
Shanghai Pulmonary Hospital, Shanghai, ChinaRecruitingNon-small Cell Lung Cancer | Locally AdvancedChina
-
National Cancer Institute, NaplesActive, not recruitingOvarian CancerItaly, Portugal, Turkey
-
M.D. Anderson Cancer CenterRecruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific
-
Insmed IncorporatedCompleted
-
Skaraborg HospitalCompletedBacterial Vaginoses
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedSarcoma | Ovarian Cancer | Fallopian Tube Cancer | Endometrial CancerUnited States
-
Claudia Lorenz-SchlüterTerminatedMetastatic Breast CancerGermany
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States, Norway
-
Massachusetts General HospitalNational Cancer Institute (NCI)CompletedNeoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast CancerBreast CancerUnited States
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Recurrent Ovarian Low Grade Serous Adenocarcinoma | Borderline Ovarian Serous Tumor | Micropapillary Serous Carcinoma | Recurrent Primary Peritoneal Serous AdenocarcinomaUnited States, United Kingdom